登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Midkine】

Midkine信息

英文名称:Midkine
中文名称:中期因子
靶点别称:Midkine,Midgestation and kidney protein,Neurite outgrowth-promoting factor 2,Neurite outgrowth-promoting protein,Amphiregulin-associated protein,NEGF2,ARAP,FLJ27379,Neurite Growth-Promoting Factor 2,Retinoic Acid Inducible Factor,MK1,MDK,MK
上市药物数量:0
临床药物数量:1
最高研发阶段:临床阶段不明

Midkine分子别名

MDK,MEK,Midkine,MK1,MKARAP,NEGF2,Retinoic acid-induced differentiation factor

Midkine分子背景

Midkine (MK or MDK), also known as neurite growth-promoting factor 2 (NEGF2), is a protein that in humans is encoded by the MDK gene. Midkine is a basic heparin-binding growth factor of low molecular weight, and forms a family with pleiotrophin (NEGF1, 46% homologous with MK). It is a nonglycosylated protein, composed of two domains held by disulfide bridges. It is a developmentally important retinoic acid-responsive gene product strongly induced during mid-gestation, hence the name midkine. Restricted mainly to certain tissues in the normal adult, it is strongly induced during oncogenesis, inflammation and tissue repair.

Midkine临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
CMK-103 CMK-103 临床阶段不明 Cellmid 心肌梗塞 详情

消息提示

请输入您的联系方式,再点击提交!

确定